ROBICHAUD, Albert Jean,MARTINEZ BOTELLA, Gabriel,SALITURO, Francesco G.,HARRISON, Boyd L.
申请号：
EP16743932
公开号：
EP3250210A4
申请日:
2016.01.26
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
or a pharmaceutically acceptable salt thereof； wherein , A, R1, R2, and R3 are as defined herein. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. The present invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of use, e.g., for treating a subject suffering from a disease or disorder described herein.
